Trade Show

PDA APAC 2026: Meet Datwyler in Incheon

Datwyler's Validated Elastomers and Closures for Sterile Biopharmaceutical Fill-Finish in Asia-Pacific

  • Joining industry leaders focused on aseptic manufacturing quality, contamination control, and container closure integrity
  • Topics: ready-to-use component formats, sterilization validation, and elastomer performance for biopharma manufacturers
  • Supporting the Asia-Pacific region in achieving the highest standards of aseptic processing
Date November 3, 2026 – November 4, 2026
Location Sheraton Grand Incheon Hotel | Incheon, South Korea
Event Overview

Supporting Aseptic Manufacturing Excellence

Datwyler is attending PDA's Asia-Pacific Aseptic Processing of Biopharmaceuticals Conference at the Sheraton Grand Incheon Hotel, a specialized forum for biopharmaceutical manufacturers across the region navigating the complexity of sterile fill-finish manufacturing.

Want to connect?

Our team is ready to engage with quality assurance, manufacturing, and regulatory professionals on best practices, exploring Datwyler's comprehensive portfolio of:

  • Ready-to-use components, pre-washed and pre-sterilized for direct use in aseptic fill-finish operations

  • High-performance NeoFlex™ and OmniFlex® elastomer platforms for biologic drug delivery

All reducing contamination risk, simplifying process validation, and supporting the documentation requirements that global regulatory approvals demand.

Solutions Spotlight

What We're Showcasing at PDA APAC: Aseptic Processing of Biopharmaceuticals Conference

Explore the solutions and technologies most relevant to this event.

Ready-to-Use Components for Aseptic Manufacturing
Featured Solution

Ready-to-Use Components for Aseptic Manufacturing

Datwyler highlights its portfolio of ready-to-use (RTU) components — pre-washed, pre-sterilized, and packaged for direct use in aseptic fill-finish operations — supporting biopharma manufacturers in achieving the highest standards of contamination control, operational efficiency, and regulatory compliance.
High-Performance Components for Biologic Drug Delivery
Featured Solution

High-Performance Components for Biologic Drug Delivery

Biologic therapies demand packaging components that deliver exceptional purity, compatibility, and performance. Datwyler's NeoFlex™ and OmniFlex® elastomer platforms are engineered to support sensitive biologic formulations, with ultra-clean manufacturing, optimized extractables profiles, and the reliability required for complex injectable drug products.
Container Closure Expertise for Asia-Pacific Pharmaceutical Manufacturers
Featured Solution

Container Closure Expertise for Asia-Pacific Pharmaceutical Manufacturers

Datwyler engages Asia-Pacific pharmaceutical manufacturers on container closure system selection, elastomer performance, and drug delivery component innovation — sharing expertise tailored to the regulatory frameworks and market dynamics shaping injectable and biologic drug production across the region.
Helpful Information

Frequently Asked Questions

What is the PDA APAC Aseptic Processing of Biopharmaceuticals Conference?
It is PDA's Asia-Pacific conference focused on aseptic manufacturing quality, contamination control, and container closure integrity.
When is the PDA APAC Aseptic Processing of Biopharmaceuticals Conference held?
The conference takes place November 3–4, 2026, at the Sheraton Grand Incheon Hotel in Incheon, South Korea.
Is Datwyler presenting at the PDA APAC Aseptic Processing of Biopharmaceuticals Conference?
Datwyler is presenting at this event; specific session details are to be announced.
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.